BIOMAT Database Logo BIOMAT Database Logo

Interaction of fibrinogen-binding tetrapeptides with fibrin oligomers and fine fibrin clots. 1986

G Schindlauer, and M D Bale, and J D Ferry

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D005337 Fibrin A protein derived from FIBRINOGEN in the presence of THROMBIN, which forms part of the blood clot. Antithrombin I
D005340 Fibrinogen Plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. Fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides A and B, the proteolytic action of other enzymes yields different fibrinogen degradation products. Coagulation Factor I,Factor I,Blood Coagulation Factor I,gamma-Fibrinogen,Factor I, Coagulation,gamma Fibrinogen
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular

Related Publications

G Schindlauer, and M D Bale, and J D Ferry
Effects of fibrinogen-binding tetrapeptides on mechanical properties of fine fibrin clots.
March 1985, Proceedings of the National Academy of Sciences of the United States of America,
G Schindlauer, and M D Bale, and J D Ferry
Clots of beta-fibrin. Viscoelastic properties, temperature dependence of elasticity, and interaction with fibrinogen-binding tetrapeptides.
March 1988, Biophysical journal,
G Schindlauer, and M D Bale, and J D Ferry
Interaction of the fibrinogen-binding tetrapeptide Gly-Pro-Arg-Pro with fine clots and oligomers of alpha-fibrin; comparisons with alpha beta-fibrin.
May 1988, Biopolymers,
G Schindlauer, and M D Bale, and J D Ferry
Identification of fibrin oligomers in sonicated fibrin clots.
January 1977, Biophysical chemistry,
G Schindlauer, and M D Bale, and J D Ferry
Impact of γ'γ' fibrinogen interaction with red blood cells on fibrin clots.
October 2018, Nanomedicine (London, England),
G Schindlauer, and M D Bale, and J D Ferry
Characterization of the interaction of recombinant apolipoprotein(a) with modified fibrinogen surfaces and fibrin clots.
January 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire,
G Schindlauer, and M D Bale, and J D Ferry
Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen.
March 2002, The Journal of biological chemistry,
G Schindlauer, and M D Bale, and J D Ferry
Truncated vitronectins: binding to immobilized fibrin and to fibrin clots, and their subsequent interaction with cells.
January 2002, Biochemical and biophysical research communications,
G Schindlauer, and M D Bale, and J D Ferry
Complex formation of crosslinked fibrin oligomers with agarose-coupled fibrinogen and fibrin.
October 1977, Hoppe-Seyler's Zeitschrift fur physiologische Chemie,
G Schindlauer, and M D Bale, and J D Ferry
Accessibility of epitopes on fibrin clots and fibrinogen gels.
April 1991, Blood,
Copied contents to your clipboard!